8-K Other Events Reg FD – Entrada Therapeutics, Inc. (0001689375) February 09
Item 7.01 Regulation FD.On February 9, 2023, Entrada Therapeutics, Inc. (“Entrada”) issued a press release announcing the closing of the Strategic Collaboration and License Agreement (the “License Agreement”) and Sublicense Agreement (the “Sublicense Agreement”) with Vertex Pharmaceuticals Incorporated (“Vertex”). A copy of the press release is furnished hereto as Exhibit 99.1.The information in this Item…
Read More “8-K Other Events Reg FD – Entrada Therapeutics, Inc. (0001689375) February 09” »